Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives
Antimicrobial resistance (AMR) is a complex threat to human health and, to date, it represents a hot topic in drug discovery. The use of non-antibiotic molecules to block resistance mechanisms is a powerful alternative to the identification of new antibiotics. Bacterial efflux pumps exert the early...
Guardado en:
Autores principales: | Giada Cernicchi, Tommaso Felicetti, Stefano Sabatini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e79a2cf4b97140a097c7c5abf29c00a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump
por: Elizabeth M. Grimsey, et al.
Publicado: (2020) -
Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets
por: Lauren E. Brooks, et al.
Publicado: (2018) -
Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition
por: Ariel M. Langevin, et al.
Publicado: (2020) -
Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> Mutants Overexpressing Efflux Pumps
por: Jorge Olivares Pacheco, et al.
Publicado: (2017) -
Combating Drug-Resistant Bacteria Using Photothermally Active Nanomaterials: A Perspective Review
por: Kawaljeet Kaur, et al.
Publicado: (2021)